Sign in
4

Changes in Ownership

Organogenesis Holdings Inc. Filed Acc 0001062993-24-004314

Chief Financial Officer acquired 160,350 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Francisco David · Chief Financial Officer

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2024-02-21 Grant or award : show line 1 in the form +160,350 428,996 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2024-02-21 Grant or award : show line 2 in the form Stock Option (Right to Buy) +289,915 289,915 D
Loading xslF345X05/form4.xml…